Effects of chronic administration of a monoclonal antibody against human renin in the marmoset.

The study investigates the effectiveness of a monoclonal antibody, R-3-36-16, against the kidney renin in humans, when administrated to marmosets. It discovered that the compound resulted in reduced blood pressure and renin activity, presenting it to be a potentially viable treatment for high blood pressure.

Introduction

• Researchers analyzed the hypotensive potency of R-3-36-16, a monoclonal antibody which tackles human kidney renin. The study was conducted on a non-human primate species – the marmoset.
• The research aimed at understanding the chronic effects of R-3-36-16 by steadily infusing it using an osmotic minipump.
• The marmosets were on a low-sodium diet and received doses of either 30 or 300 micrograms/kg/day for two consecutive weeks.

Results

• The lower dose of the antibody did not have any significant effect on either the blood pressure (BP) or plasma renin activity (PRA) of the subjects.
• On administering the higher dose, PRA saw a reduction of 57% and a prominent decrease in blood pressure, by 13 ± 7 mm Hg, after just two days of treatment.
• The hypotensive response observed persisted even after the two-week treatment, reducing BP by 17 ± 2 mm Hg. However, PRA values observed a return back to their pretreatment levels.

Post-Treatment Observation

• Once the treatment was stopped, blood pressure values slowly returned to their initial state over a week.
• Seven weeks after discontinuing the treatment, an acute dosage of R-3-36-16 was given to the subjects to test for any potential immune reactions. The claim that none were observed supports the safe use of the drug for extended periods of time.

Conclusion

• The study concluded that R-3-36-16 could serve as an efficacious and well-tolerated hypotensive agent during chronic administration to sodium-depleted primates.
• The researchers also noted that the reduction in blood pressure does not seem to be directly aligned with the inhibition of renin in plasma, suggesting that more research is required to fully understand the underlying mechanism of action.